J.-F. Besancenot

1.1k total citations
47 papers, 542 citations indexed

About

J.-F. Besancenot is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, J.-F. Besancenot has authored 47 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 16 papers in Pulmonary and Respiratory Medicine and 8 papers in Genetics. Recurrent topics in J.-F. Besancenot's work include Systemic Lupus Erythematosus Research (10 papers), Vasculitis and related conditions (9 papers) and Urticaria and Related Conditions (4 papers). J.-F. Besancenot is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Vasculitis and related conditions (9 papers) and Urticaria and Related Conditions (4 papers). J.-F. Besancenot collaborates with scholars based in France, Switzerland and Cambodia. J.-F. Besancenot's co-authors include P. Bielefeld, J. Vinit, G. Müller, Bernard Bonnotte, Alain M. Bron, Samuel Bidot, F. Maurier, B. Lorcerie, Sylvain Audia and N. Magy‐Bertrand and has published in prestigious journals such as American Journal of Ophthalmology, Movement Disorders and Medicine.

In The Last Decade

J.-F. Besancenot

45 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-F. Besancenot France 13 294 188 95 93 62 47 542
Döndü Üsküdar Cansu Türkiye 13 286 1.0× 124 0.7× 51 0.5× 158 1.7× 40 0.6× 86 650
F. Ortíz-Sanjuán Spain 13 256 0.9× 301 1.6× 48 0.5× 44 0.5× 47 0.8× 43 581
Deva Situnayake United Kingdom 13 575 2.0× 89 0.5× 99 1.0× 155 1.7× 40 0.6× 24 783
Shinobu Waga Japan 14 118 0.4× 131 0.7× 36 0.4× 87 0.9× 55 0.9× 58 560
Gülşen Özen Türkiye 13 372 1.3× 54 0.3× 35 0.4× 98 1.1× 65 1.0× 31 590
J. Bosch Spain 9 249 0.8× 227 1.2× 59 0.6× 43 0.5× 28 0.5× 23 706
G S Alarcón United States 12 394 1.3× 40 0.2× 31 0.3× 93 1.0× 50 0.8× 23 585
Xavier Belenfant France 11 156 0.5× 319 1.7× 19 0.2× 70 0.8× 111 1.8× 27 740
J Mooney United Kingdom 7 357 1.2× 537 2.9× 18 0.2× 93 1.0× 142 2.3× 11 730
Linlin Cheng China 11 97 0.3× 81 0.4× 30 0.3× 59 0.6× 50 0.8× 46 628

Countries citing papers authored by J.-F. Besancenot

Since Specialization
Citations

This map shows the geographic impact of J.-F. Besancenot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-F. Besancenot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-F. Besancenot more than expected).

Fields of papers citing papers by J.-F. Besancenot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-F. Besancenot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-F. Besancenot. The network helps show where J.-F. Besancenot may publish in the future.

Co-authorship network of co-authors of J.-F. Besancenot

This figure shows the co-authorship network connecting the top 25 collaborators of J.-F. Besancenot. A scholar is included among the top collaborators of J.-F. Besancenot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-F. Besancenot. J.-F. Besancenot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samson, Maxime, H. Devilliers, K.H. Ly, et al.. (2018). Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. European Journal of Internal Medicine. 57. 96–104. 30 indexed citations
2.
Blanc, Christelle, Hervé Devilliers, Maxime Samson, et al.. (2018). Associated arterial and venous cerebral manifestations in Behçet's disease. Revue Neurologique. 174(5). 337–341. 5 indexed citations
3.
Bielefeld, P., et al.. (2016). Œil et maladie des griffes du chat : à propos de 7 cas. Journal Français d Ophtalmologie. 39(2). 164–170. 2 indexed citations
4.
Putot, Alain, Sophie Perrin, Henri Bailly, et al.. (2016). A New Prognosis Score to Predict Mortality After Acute Pneumonia in Very Elderly Patients. Journal of the American Medical Directors Association. 17(12). 1123–1128. 13 indexed citations
5.
Bouiller, Kévin, Sylvain Audia, H. Devilliers, et al.. (2016). Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement. Medicine. 95(28). e4238–e4238. 33 indexed citations
6.
Salles, Belmiro Freitas de, P. Bielefeld, G. Müller, et al.. (2016). Nécrose médullaire paranéoplasique: une entité rare de syndrome fébrile avec élévation significative de la procalcitonine. La Revue de Médecine Interne. 37. A140–A141.
7.
Putot, Alain, Sophie Perrin, Henri Bailly, et al.. (2016). Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients. European Journal of Clinical Microbiology & Infectious Diseases. 35(3). 489–495. 15 indexed citations
8.
Bielefeld, P., Hervé Devilliers, David Saadoun, et al.. (2015). Potential of Pegylated Interferon Alpha-2a in Behçet Uveitis: A Report of Five Cases. Ocular Immunology and Inflammation. 24(5). 1–4. 9 indexed citations
9.
Devilliers, Hervé, J.-F. Besancenot, Bernard Bonnotte, et al.. (2014). Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE. Lara D. Veeken. 54(5). 940–949. 56 indexed citations
10.
Vinit, J., P. Bielefeld, G. Müller, & J.-F. Besancenot. (2012). Efficacy of tocilizumab in refractory giant cell arteritis. Joint Bone Spine. 79(3). 317–318. 33 indexed citations
11.
Devilliers, Hervé, Zahir Amoura, J.-F. Besancenot, et al.. (2012). LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus. Lara D. Veeken. 51(10). 1906–1915. 41 indexed citations
12.
Bielefeld, P., et al.. (2011). Efficacy of Tocilizumab in Two Patients with anti-TNF-alpha Refractory Uveitis. Ocular Immunology and Inflammation. 19(5). 382–383. 77 indexed citations
13.
14.
Vinit, J., et al.. (2010). Syndrome de Birt-Hogg-Dubé et tumeurs multiples récidivantes. La Revue de Médecine Interne. 32(3). e40–e42. 4 indexed citations
15.
Vinit, J., P. Bielefeld, G. Müller, et al.. (2010). Heart involvement in Churg–Strauss syndrome: Retrospective study in French Burgundy population in past 10years. European Journal of Internal Medicine. 21(4). 341–346. 30 indexed citations
16.
Vinit, J., G. Müller, P. Bielefeld, et al.. (2009). Churg–Strauss syndrome: retrospective study in Burgundian population in France in past 10 years. Rheumatology International. 31(5). 587–593. 17 indexed citations
17.
Fayard, Maxime, et al.. (2006). Cœur et congélateur : à propos d'un cas d'hyperéosinophilie et de spasme coronaire. Annales de Cardiologie et d Angéiologie. 55(4). 222–226. 1 indexed citations
18.
19.
Bielefeld, P., et al.. (1997). Bilateral Loss of Vision and Macular Ischemia Related to Behçet Disease. American Journal of Ophthalmology. 124(1). 116–117. 9 indexed citations
20.
Guillevin, Loı̈c, J.Y. Borg, J.-F. Besancenot, et al.. (1988). Anticoagulants circulants en dehors de l'hémophilie: Enquête multicentrique conduite par le secrétariat à la recherche de la SNFMI à propos de 207 observations. La Revue de Médecine Interne. 9(1). 33–39. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Döndü Üsküdar Cansu Breakdown of academic impact, for papers by F. Ortíz-Sanjuán Breakdown of academic impact, for papers by Deva Situnayake Breakdown of academic impact, for papers by Shinobu Waga Breakdown of academic impact, for papers by Gülşen Özen Breakdown of academic impact, for papers by J. Bosch Breakdown of academic impact, for papers by G S Alarcón Breakdown of academic impact, for papers by Xavier Belenfant Breakdown of academic impact, for papers by J Mooney Breakdown of academic impact, for papers by Linlin Cheng
Rankless by CCL
2026